| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e388bf6eccba6baf7f83da6f6b790343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7152b10698d14f3506722e7a06cafbfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13fcb85826dff0bcf6af14111d5e48d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21073 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2002-03-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ce672eed8d6194951842f7bddbaddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec0e7590dd4336f1f181b56926b84cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8b7ff8a0bb48ef22c6a87aa158444c |
| publicationDate |
2002-10-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02079515-A1 |
| titleOfInvention |
Antisense modulation of urokinase plasminogen activator expression |
| abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of urokinase plasminogen activator. The composition comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding urokinase plasminogen activator. Method of using these compounds for modulation of urokinase plasminogen activator expression and for treatment of diseases associated with expression of urokinase plasminogen activator are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025219-B |
| priorityDate |
2001-03-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |